Editorial: AI and new digital technologies have transformed alcohol and other drug industries lobbying

被引:1
|
作者
Rychert, Marta [1 ]
Sultan, Aysel [2 ]
Mialon, Melissa [3 ]
机构
[1] Massey Univ, SHORE & Whariki Res Ctr, Auckland, New Zealand
[2] Tech Univ Munich, Dept Sci Technol & Soc, Munich, Germany
[3] Univ Rennes, EHESP, CNRS, Inserm,Arenes UMR 6051,RSMS Rech Serv & Management, Rennes, France
来源
DRUGS HABITS AND SOCIAL POLICY | 2024年 / 25卷 / 01期
关键词
MEDIA;
D O I
10.1108/DHS-05-2024-072
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [41] Special Section on New and Emerging Areas and Technologies in Drug Metabolism and Disposition, Part I-Editorial
    Zhong, Xiao-bo
    Lai, Yurong
    Ding, Xinxin
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (10) : 1227 - 1229
  • [42] Editorial overview: New technologies: drug delivery and medical devices combinations, more than the sum of the parts
    Brayden, David J.
    Hirst, Barry H.
    CURRENT OPINION IN PHARMACOLOGY, 2017, 36 : IV - VII
  • [43] Prevention of alcohol and other drug use and related harm in the digital age: what does the evidence tell us?
    Champion, Katrina E.
    Newton, Nicola C.
    Teesson, Maree
    CURRENT OPINION IN PSYCHIATRY, 2016, 29 (04) : 242 - 249
  • [44] Editorial: 'Do we really need another review on the effects of physical activity on alcohol and other drug use disorders?'
    Taylor, Adrian H.
    Thompson, Tom P.
    Horrell, Jane
    MENTAL HEALTH AND PHYSICAL ACTIVITY, 2020, 19
  • [45] Development of a Routine Outcome Monitoring Instrument for Use with Clients in the New Zealand Alcohol and Other Drug Treatment Sector: the Alcohol and Drug Outcome Measure (ADOM)
    Pulford, Justin
    Deering, Daryle E.
    Robinson, Gail
    Wheeler, Amanda
    Adamson, Simon J.
    Frampton, Christopher M. A.
    Dunbar, Lucy
    Paton-Simpson, Grant
    NEW ZEALAND JOURNAL OF PSYCHOLOGY, 2010, 39 (03) : 35 - 45
  • [46] Considerations in providing shared-care psychological treatment for clients who have alcohol or other drug misuse problems
    Digiusto, Erol
    Friend, Rowena
    Batey, Robert G.
    Mattick, Richard P.
    CLINICAL PSYCHOLOGIST, 2013, 17 (03) : 100 - 105
  • [48] PRYOR INTRODUCES LEGISLATION TO BRING GENERIC DRUG MANUFACTURERS IN-LINE WITH OTHER INDUSTRIES AFFECTED BY NEW PATENT TERM
    MARKS, MS
    BIOTECHNOLOGY LAW REPORT, 1995, 14 (04): : 587 - 591
  • [49] The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing?
    Andreadis, Ioannis I.
    Gioumouxouzis, Christos, I
    Eleftheriadis, Georgios K.
    Fatouros, Dimitrios G.
    PHARMACEUTICS, 2022, 14 (03)
  • [50] The Availability of Alcohol, Tobacco, and Other Drug Services for Adolescents in New York State Community Health Centers
    Haley, Sean J.
    Moscou, Susan
    Murray, Sharifa
    Rieckmann, Traci
    Wells, Kameron
    JOURNAL OF DRUG ISSUES, 2018, 48 (01) : 78 - 89